Source: Nature Immunology, by Simon Koplev; Osheen Sharma; Simon Woelfel; Ni Huang; Mathilde Pohin; Adrian Feile; Maria Warschinke; Mikel Rezola Artero; Sharujan Suthakaran; Ioannis Sarropoulos; J Patrick Pett; Julia Nyman; Tom Thomas; Duy Pham; Bin Li; Moustafa Attar; Julia Pakpoor; Kate Milosevic-Hutton; Alistair Easton; Matt Butler. AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- Researchers profiled about 2.5 million cells and identified 18 stromal cell states in full-thickness Crohn's disease bowel.
- Inflammatory fibroblasts in immune-rich ulcers were stabilized by GLI3, TWIST1, ETV4, PRDM1, and RELB activity.
- The study does not establish clinical safety, dosing, or patient benefit for histone deacetylase inhibition in Crohn's disease.
Researchers have mapped how support cells in the bowel acquire and retain harmful identities in active Crohn's disease, pointing to an epigenetic route for potentially disrupting inflammatory tissue niches. The study examined about 2.5 million cells from human full-thickness Crohn's disease bowel using single-cell spatial transcriptomics, RNA sequencing, and ATAC sequencing. It identified 18 distinct stromal cell states, the connective-tissue cell programs that help build, maintain, and repair organs. One particularly important state, inflammatory fibroblasts, clustered in mucosal ulcers packed with immune cells. These fibroblasts were driven by combinations of cytokines, the immune system's chemical messengers, and they did not readily return to a baseline state on their own. The researchers found that inhibiting histone deacetylases, enzymes that help control which genes cells can access, destabilized this inflammatory state in experimental work. The result connects a cell's local neighborhood, its gene-control machinery, and the persistent inflammation and scarring that characterize Crohn's disease. It also suggests that treating disease may require changing the tissue environment and the durable cell states it creates, rather than only suppressing immune signals.
A detailed map of diseased bowel tissue
Crohn's disease is an inflammatory bowel disease in which inflammation can extend through the full thickness of the intestinal wall. While immune cells are central to the condition, stromal cells also shape the physical and chemical setting in which inflammation persists, influencing wound repair, fibrosis, and communication with neighboring cells.
The researchers combined several complementary tools to examine these cells in their native setting. Single-cell spatial transcriptomics identifies gene activity in individual cells while preserving information about where those cells sit in tissue, much like reading both the words on a page and their position in a diagram. RNA sequencing measured which genes were being used, while ATAC sequencing assessed open chromatin, regions of DNA that are accessible to gene-regulating proteins.
Inflammatory fibroblasts occupy ulcer niches
Across the dataset, the team identified 18 stromal cell states and placed them within their surrounding cell populations and cytokine-signaling environments. This matters because a fibroblast is not one fixed entity: its behavior can change depending on nearby immune cells, structural signals, and inflammatory molecules.
Inflammatory fibroblasts, abbreviated IFs in the study, were located in mucosal ulcers rich in immune cells. The mucosa is the bowel's inner lining, so ulcers in this layer are directly exposed to a dense mix of immune activity and damaged epithelial tissue, the cell layer that forms the intestine's barrier.
Signals combine to change cell identity
The study found that inflammatory fibroblasts were induced through combinatorial cytokine exposure. In plain terms, no single inflammatory message tells the full story. Instead, several signals arriving together act more like a chord than a lone musical note, pushing fibroblasts into a distinct inflammatory program.
As this program emerged, it suppressed what the researchers call submucosal universal fibroblast programs. The submucosa is a deeper tissue layer beneath the lining, and these broader fibroblast programs appear to be displaced as cells adopt the ulcer-associated inflammatory identity.
Why the state can persist
A major question in chronic inflammation is whether altered cells simply respond moment by moment to their environment or whether they acquire a more lasting identity. The study indicates that the inflammatory fibroblast state is stabilized by the activity of five transcription factors: GLI3, TWIST1, ETV4, PRDM1, and RELB.
Transcription factors are proteins that help switch genes on and off, similar to managers deciding which instructions in a large operations manual are available to a team. Their activity was linked to the inflammatory fibroblast program, and the researchers reported that this state did not spontaneously revert, suggesting that the cells retain a durable molecular memory of the inflammatory niche.
Epigenetic control offers a way to disrupt the program
The durability of the inflammatory state was associated with its open-chromatin configuration. Chromatin is the packaging around DNA, and its openness determines whether cellular machinery can reach particular genes. An open configuration can therefore make a gene program easier for a cell to repeatedly use.
When the researchers used histone deacetylase inhibition, they destabilized the inflammatory fibroblast state. Histone deacetylases are enzymes that modify histones, proteins around which DNA is wrapped, and inhibiting them can alter which stretches of DNA remain available for gene control. The finding does not establish a treatment for Crohn's disease, but it shows that this cell state is not molecularly immovable.
Effects on epithelial cells and neutrophils
The study also tested consequences of the inflammatory fibroblast secretome, the mixture of molecules released by these cells. With histone deacetylase inhibition, the researchers prevented the secretome from inducing epithelial transmigration and from activating neutrophils, immune cells that can intensify inflammation.
This experiment gives the fibroblast state functional weight beyond a descriptive cell map. It suggests that inflammatory fibroblasts can send signals that influence the intestinal barrier and recruit or stimulate inflammatory responses, helping maintain the ulcer environment in which they reside.
A separate niche for fibrosis
The inflammatory fibroblast program was not the only altered stromal pattern. Its open-chromatin configuration differed from that of fibrotic contractile stroma, cells associated with tissue tightening and scarring. These fibrotic stromal cells occupied adjoining submucosal niches that were relatively depleted of immune cells.
The contrast is important because Crohn's disease can include both active inflammation and fibrosis, yet these processes may be organized in neighboring but biologically distinct tissue compartments. The work argues that local microenvironments help shape which stromal state appears, rather than treating the diseased bowel wall as one uniform inflammatory space.
Why This Matters
Current thinking about Crohn's disease often centers on interrupting immune pathways, and immune-directed therapies remain important. This study adds a more spatial view: immune cells, cytokines, epithelial cells, and stromal cells can form self-reinforcing local niches, with epigenetic gene regulation helping lock certain cells into harmful roles.
That framing could guide future research toward therapies designed for particular tissue niches, including approaches that alter stromal programs alongside immune activity. Still, the source does not provide clinical trial evidence, patient outcomes, dosing strategies, or proof that histone deacetylase inhibitors can safely reverse these processes in people with Crohn's disease.
The next step is to determine whether these mapped cell states predict disease course, treatment response, or complications such as fibrosis. Researchers will also need to identify whether modulating epigenetic control can selectively weaken harmful inflammatory fibroblasts without disrupting the normal repair functions that stromal cells perform throughout the intestine.